-
Panel discussion to explore stem cell-derived beta cell therapy for type 1 diabetes
Sanjoy Dutta, PhD, Jay Skyler, MD, and other panelists will share insights on advances in the use of manufactured islets and what it might take to achieve widespread clinical use.
-
New clinical trial results to debut daily in New Orleans
Investigators will present high-impact results for type 1 diabetes, type 2 diabetes, and obesity in several clinical trial sessions. Glucagon-like peptide-1 (GLP-1)-based therapies—including dual and triple agonists, oral agents, and longer acting formulations—will be a recurring topic.
-
Join the ADA in New Orleans for the 2026 Scientific Sessions
Experts from across the globe will convene to share the latest cutting-edge advances in diabetes research, prevention, and care June 5–8 as part of an education program featuring 200 sessions across 25 topic areas.